NASDAQ:OTLK - Outlook Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.79 +0.83 (+42.35 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$1.96
Today's Range$2.23 - $2.8852
52-Week Range$0.85 - $10.96
Volume25.54 million shs
Average Volume2.76 million shs
Market Capitalization$32.67 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

Headlines

Outlook Therapeutics (NASDAQ OTLK) News Headlines

Source:
DateHeadline
Thinking about buying stock in Aurora Cannabis, Nobilis Health, Maxar Technologies, Netshoes, or Outlook Therapeutics?Thinking about buying stock in Aurora Cannabis, Nobilis Health, Maxar Technologies, Netshoes, or Outlook Therapeutics?
www.benzinga.com - May 24 at 3:34 PM
Outlook Therapeutics: A Perfect Storm Of Positive Catalysts Driving Share Price UpOutlook Therapeutics: A Perfect Storm Of Positive Catalysts Driving Share Price Up
seekingalpha.com - May 20 at 3:38 PM
S, TMUS among premarket gainersS, TMUS among premarket gainers
seekingalpha.com - May 20 at 9:49 AM
Outlook Therapeutics stock rockets on heavy volume again, set to triple in 3 daysOutlook Therapeutics stock rockets on heavy volume again, set to triple in 3 days
finance.yahoo.com - May 20 at 9:49 AM
Outlook Therapeutics stock rockets on heavy volume again, has more than doubled in 2 daysOutlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days
www.marketwatch.com - May 17 at 3:34 PM
Outlook Therapeutics Rallies 150% In 2 Days: What You Need To KnowOutlook Therapeutics Rallies 150% In 2 Days: What You Need To Know
www.benzinga.com - May 17 at 3:34 PM
Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 daysOutlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days
finance.yahoo.com - May 17 at 3:34 PM
Outlook Therapeutics started at outperform with $12 stock price target at OppenheimerOutlook Therapeutics started at outperform with $12 stock price target at Oppenheimer
finance.yahoo.com - May 16 at 3:35 PM
Outlook Therapeutics (OTLK) Earns Outperform Rating from Analysts at CIBCOutlook Therapeutics (OTLK) Earns Outperform Rating from Analysts at CIBC
www.americanbankingnews.com - May 16 at 12:09 PM
Outlook Therapeutics (OTLK) Now Covered by OppenheimerOutlook Therapeutics (OTLK) Now Covered by Oppenheimer
www.americanbankingnews.com - May 16 at 9:55 AM
Outlook Therapeutics (OTLK) Announces Quarterly  Earnings Results, Beats Expectations By $0.08 EPSOutlook Therapeutics (OTLK) Announces Quarterly Earnings Results, Beats Expectations By $0.08 EPS
www.americanbankingnews.com - May 16 at 9:12 AM
Outlook Therapeutics beats by $0.08, misses on revenueOutlook Therapeutics beats by $0.08, misses on revenue
seekingalpha.com - May 15 at 8:22 AM
Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
finance.yahoo.com - May 15 at 8:22 AM
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical DevelopmentOutlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
finance.yahoo.com - April 26 at 9:35 AM
Outlook Therapeutics down 42% on pricing equity offeringOutlook Therapeutics down 42% on pricing equity offering
seekingalpha.com - April 10 at 10:40 AM
Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and WarrantsOutlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
finance.yahoo.com - April 10 at 10:40 AM
Outlook files for downsized equity offering; shares off 11%Outlook files for downsized equity offering; shares off 11%
seekingalpha.com - April 9 at 3:43 PM
FDA accepts Outlook Therapeutics IND for ONS-5010FDA accepts Outlook Therapeutics' IND for ONS-5010
seekingalpha.com - April 1 at 3:30 PM
Outlook Therapeutics Announces FDA Acceptance of IND for ONS-5010Outlook Therapeutics Announces FDA Acceptance of IND for ONS-5010
finance.yahoo.com - April 1 at 9:13 AM
Outlook Therapeutics Inc.Outlook Therapeutics Inc.
www.barrons.com - March 22 at 7:32 AM
Outlook Therapeutics IncOutlook Therapeutics Inc
www.bloomberg.com - March 20 at 8:33 AM
Outlook Therapeutics reverse splits shares 1:8Outlook Therapeutics reverse splits shares 1:8
seekingalpha.com - March 15 at 3:26 PM
Outlook Therapeutics Announces Reverse Stock SplitOutlook Therapeutics Announces Reverse Stock Split
finance.yahoo.com - March 15 at 3:26 PM
Outlook Therapeutics files for $50M stock offering; shares down 7% premarketOutlook Therapeutics files for $50M stock offering; shares down 7% premarket
seekingalpha.com - March 7 at 7:51 AM
Outlook Therapeutics Regains Compliance With All Nasdaq Listing RequirementsOutlook Therapeutics Regains Compliance With All Nasdaq Listing Requirements
finance.yahoo.com - March 5 at 8:26 AM
Outlook advancing eye disease candidate ONS-5010Outlook advancing eye disease candidate ONS-5010
seekingalpha.com - March 1 at 3:25 PM
Outlook Therapeutics Submits IND Application for ONS-5010 to the FDAOutlook Therapeutics Submits IND Application for ONS-5010 to the FDA
finance.yahoo.com - March 1 at 8:28 AM
These 4 Tech Stocks Could Have A Banner DayThese 4 Tech Stocks Could Have A Banner Day
www.baystreet.ca - February 14 at 3:22 PM
Outlook Therapeutics up 18%Outlook Therapeutics up 18%
seekingalpha.com - February 14 at 3:22 PM
Healthcare Investment Opportunities You Cant MissHealthcare Investment Opportunities You Can't Miss
finance.yahoo.com - February 13 at 3:23 PM
Outlook Therapeutics Closes Final Tranche of $20 Million Private PlacementOutlook Therapeutics Closes Final Tranche of $20 Million Private Placement
finance.yahoo.com - February 1 at 3:22 PM
Outlook Therapeutics Announces Exercise Price Reduction and Term Extension of Series A WarrantsOutlook Therapeutics Announces Exercise Price Reduction and Term Extension of Series A Warrants
finance.yahoo.com - January 22 at 3:21 PM
Big paychecks: Heres the typical employee salary at Netflix, Facebook, Google, Salesforce, Microsoft and 40 other tech employersBig paychecks: Here's the typical employee salary at Netflix, Facebook, Google, Salesforce, Microsoft and 40 other tech employers
www.bizjournals.com - January 2 at 3:16 PM
Outlook Therapeutics Closes Third Tranche of $20 Million Private PlacementOutlook Therapeutics Closes Third Tranche of $20 Million Private Placement
finance.yahoo.com - January 2 at 3:16 PM
Global Myelofibrosis Therapeutics Market 2018-2022| High Off-Label Prescription to Boost Demand | TechnavioGlobal Myelofibrosis Therapeutics Market 2018-2022| High Off-Label Prescription to Boost Demand | Technavio
www.bizjournals.com - December 28 at 3:15 PM
Kala Pharmaceuticals: Update And 2019 OutlookKala Pharmaceuticals: Update And 2019 Outlook
seekingalpha.com - December 28 at 3:15 PM
Global Breast Cancer Therapeutics Market 2019-2023 | Rise in Strategic Collaborations to Boost Growth | TechnavioGlobal Breast Cancer Therapeutics Market 2019-2023 | Rise in Strategic Collaborations to Boost Growth | Technavio
www.businesswire.com - December 26 at 3:15 PM
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: What is a Futures Contract?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel